Sinarest LEVO Uses

Was this medicine useful for you?
sponsored

What is Sinarest LEVO?

Sinarest LEVO (Sinarest LEVO) is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).

Sinarest LEVO is used to treat nasal and sinus congestion, or congestion of the tubes that drain fluid from your inner ears, called the eustachian (yoo-STAY-shun) tubes.

Sinarest LEVO may also be used for purposes not listed in this medication guide.

Sinarest LEVO indications

An indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Sinarest LEVO is used for the temporary relief of stuffy nose, sinus, and ear symptoms caused by the common cold, flu, allergies, or other breathing illnesses (e.g., sinusitis, bronchitis). This medication works by decreasing swelling in the nose and ears, thereby lessening discomfort and making it easier to breathe.

Cough-and-cold products have not been shown to be safe or effective in children younger than 6 years. Therefore, do not use this product to treat cold symptoms in children younger than 6 years unless specifically directed by the doctor. Some products (such as long-acting tablets/capsules) are not recommended for use in children younger than 12 years. Ask your doctor or pharmacist for more details about using your product safely.

How should I use Sinarest LEVO?

Use Sinarest LEVO drops as directed by your doctor. Check the label on the medicine for exact dosing instructions.

Ask your health care provider any questions you may have about how to use Sinarest LEVO drops.

Uses of Sinarest LEVO in details

There are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Use: Labeled Indications

Hypotension/shock: Treatment of hypotension, vascular failure in shock. Note: Not recommended for routine use in the treatment of septic shock; use should be limited until more evidence demonstrating positive clinical outcomes becomes available (Rhodes 2017).

Guideline recommendations:

Cardiogenic shock: The 2017 American Heart Association (AHA) scientific statement for the Contemporary Management of Cardiogenic Shock recommends Sinarest LEVO, if needed, be considered for initial vasoactive management of cardiogenic shock due to aortic stenosis, mitral stenosis, or dynamic left ventricular outflow tract (LVOT) obstruction (AHA [van Diepen 2017]).

Hypotension during anesthesia: As a vasoconstrictor in regional analgesia

Nasal congestion: As a decongestant [OTC]

Off Label Uses

Hypotension in patients with obstructive hypertrophic cardiomyopathy

Sinarest LEVO is a pure alpha1 agonist that will increase systemic vascular resistance without increasing heart rate or contractility. This is advantageous in patients with obstructive hypertrophic cardiomyopathy and hypotension since increases in both heart rate and contractility may cause the obstruction to worsen, leading to a decrease in cardiac output. Other vasopressors like dopamine, epinephrine, and norepinephrine may increase contractility and/or heart rate. Additional trials may be necessary to further define the role of Sinarest LEVO in this condition.

Based on the American Urological Association guidelines for the management of priapism, due to the low risk of cardiovascular side effects intracavernous injection of Sinarest LEVO is recommended for ischemic priapism that persists following aspiration/irrigation.

Sinarest LEVO description

sponsored

Sinarest LEVO is a sympathomimetic amine that acts predominantly on α-adrenergic receptors. It is mainly used to treat nasal congestion, but may also be useful in treating hypotension and shock, hypotension during spinal anaesthesia, prolongation of spinal anaesthesia, paroxysmal supraventricular tachycardia, symptomatic relief of external or internal hemorrhoids, and to increase blood pressure as an aid in the diagnosis of heart murmurs.

Sinarest LEVO dosage

Sinarest LEVO Dosage

Generic name: Sinarest LEVO HYDROCHLORIDE 10mg in 1mL

Dosage form: injection

The information at Drugs.com is not a substitute for medical advice. Always consult your doctor or pharmacist.

General Dosage and Administration Instructions

Sinarest LEVO (Sinarest LEVO hydrochloride) Injection, 10 mg/mL must be diluted before administration as an intravenous bolus or continuous intravenous infusion to achieve the desired concentration:

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration. Do not use if the solution is colored or cloudy, or if it contains particulate matter. The diluted solution should not be held for more than 4 hours at room temperature or for more than 24 hours under refrigerated conditions. Discard any unused portion.

During Sinarest LEVO administration:

Dosing for Treatment of Hypotension during Anesthesia

The following are the recommended dosages for the treatment of hypotension during anesthesia.

Prepare a 100 mcg/mL Solution for Bolus

Intravenous Administration

For bolus intravenous administration, prepare a solution containing a final concentration of 100 mcg/mL of Sinarest LEVO:

Prepare a Solution for Continuous

Intravenous Administration

For continuous intravenous infusion, prepare a solution containing a final concentration of 20 mcg/mL of Sinarest LEVO in 5% Dextrose Injection, USP or 0.9% Sodium Chloride Injection, USP:

Directions for Dispensing from Pharmacy Bulk Vial

The Pharmacy Bulk Vial is intended for dispensing of single doses to multiple patients in a pharmacy admixture program and is restricted to the preparation of admixtures for infusion. Each closure shall be penetrated only one time with a suitable sterile transfer device or dispensing set that allows measured dispensing of the contents. The Pharmacy Bulk Vial is to be used only in a suitable work area such as a laminar flow hood (or an equivalent clean air compounding area). Dispensing from a pharmacy bulk vial should be completed within 4 hours after the vial is penetrated.

More about Sinarest LEVO (Sinarest LEVO)

Consumer resources

Professional resources

Related treatment guides

Sinarest LEVO interactions

See also:
What other drugs will affect Sinarest LEVO?

sponsored

Acetaminophen: May increase the serum concentration of Sinarest LEVO (Systemic). Monitor therapy

Alpha1-Blockers: May diminish the vasoconstricting effect of Alpha1-Agonists. Similarly, Alpha1-Agonists may antagonize Alpha1-Blocker vasodilation. Monitor therapy

AtoMOXetine: May enhance the hypertensive effect of Sympathomimetics. AtoMOXetine may enhance the tachycardic effect of Sympathomimetics. Monitor therapy

Benzylpenicilloyl Polylysine: Alpha1-Agonists may diminish the diagnostic effect of Benzylpenicilloyl Polylysine. Management: Consider use of a histamine skin test as a positive control to assess a patient's ability to mount a wheal and flare response. Consider therapy modification

Cannabinoid-Containing Products: May enhance the tachycardic effect of Sympathomimetics. Exceptions: Cannabidiol. Monitor therapy

Chloroprocaine: May enhance the hypertensive effect of Sinarest LEVO (Systemic). Monitor therapy

CloZAPine: May diminish the therapeutic effect of Sinarest LEVO (Systemic). Monitor therapy

Cocaine (Topical): May enhance the hypertensive effect of Sympathomimetics. Management: Consider alternatives to use of this combination when possible. Monitor closely for substantially increased blood pressure or heart rate and for any evidence of myocardial ischemia with concurrent use. Consider therapy modification

Doxofylline: Sympathomimetics may enhance the adverse/toxic effect of Doxofylline. Monitor therapy

Ergot Derivatives: May enhance the hypertensive effect of Alpha1-Agonists. Ergot Derivatives may enhance the vasoconstricting effect of Alpha1-Agonists. Exceptions: Ergoloid Mesylates; Nicergoline. Avoid combination

FentaNYL: Alpha1-Agonists may decrease the serum concentration of FentaNYL. Specifically, fentanyl nasal spray serum concentrations may decrease and onset of effect may be delayed. Monitor therapy

Guanethidine: May enhance the arrhythmogenic effect of Sympathomimetics. Guanethidine may enhance the hypertensive effect of Sympathomimetics. Monitor therapy

Hyaluronidase: May enhance the vasoconstricting effect of Sinarest LEVO (Systemic). Management: Avoid the use of hyaluronidase to enhance dispersion or absorption of Sinarest LEVO. Use of hyaluronidase for other purposes in patients receiving Sinarest LEVO may be considered as clinically indicated. Avoid combination

Iobenguane Radiopharmaceutical Products: Alpha1-Agonists may diminish the therapeutic effect of Iobenguane Radiopharmaceutical Products. Management: Discontinue all drugs that may inhibit or interfere with catecholamine transport or uptake for at least 5 biological half-lives before iobenguane administration. Do not administer these drugs until at least 7 days after each iobenguane dose. Avoid combination

Ioflupane I 123: Sinarest LEVO (Systemic) may diminish the diagnostic effect of Ioflupane I 123. Monitor therapy

Linezolid: May enhance the hypertensive effect of Sympathomimetics. Management: Reduce initial doses of sympathomimetic agents, and closely monitor for enhanced pressor response, in patients receiving linezolid. Specific dose adjustment recommendations are not presently available. Consider therapy modification

Monoamine Oxidase Inhibitors: May enhance the hypertensive effect of Alpha1-Agonists. While linezolid is expected to interact via this mechanism, management recommendations differ from other monoamine oxidase inhibitors. Refer to linezolid specific monographs for details. Exceptions: Linezolid. Avoid combination

Ozanimod: May enhance the hypertensive effect of Sympathomimetics. Management: Concomitant use of ozanimod with sympathomimetic agents is not recommended. If combined, monitor patients closely for the development of hypertension, including hypertensive crises. Consider therapy modification

Propacetamol: May increase the serum concentration of Sinarest LEVO (Systemic). Management: Monitor patients closely for increased side effects of Sinarest LEVO if propacetamol is used concomitantly. Patients with underlying blood pressure issues or arrhythmias may need closer monitoring and may warrant consideration of alternative therapies. Monitor therapy

Solriamfetol: Sympathomimetics may enhance the hypertensive effect of Solriamfetol. Sympathomimetics may enhance the tachycardic effect of Solriamfetol. Monitor therapy

Sympathomimetics: May enhance the adverse/toxic effect of other Sympathomimetics. Monitor therapy

Tedizolid: May enhance the hypertensive effect of Sympathomimetics. Tedizolid may enhance the tachycardic effect of Sympathomimetics. Monitor therapy

Tricyclic Antidepressants: May enhance the therapeutic effect of Alpha1-Agonists. Tricyclic Antidepressants may diminish the therapeutic effect of Alpha1-Agonists. Monitor therapy

Sinarest LEVO side effects

See also:
What are the possible side effects of Sinarest LEVO?

Applies to Sinarest LEVO: intravenous solution

In addition to its needed effects, some unwanted effects may be caused by Sinarest LEVO (the active ingredient contained in Sinarest LEVO). In the event that any of these side effects do occur, they may require medical attention.

If any of the following side effects occur while taking Sinarest LEVO, check with your doctor or nurse immediately:

Incidence not known:

If any of the following symptoms of overdose occur while taking Sinarest LEVO, get emergency help immediately:

Symptoms of overdose:

Minor Side Effects

Some of the side effects that can occur with Sinarest LEVO may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

Incidence not known:

Sinarest LEVO contraindications

See also:
What is the most important information I should know about Sinarest LEVO?

Minims Sinarest LEVO hydrochloride should not be used in patients with severe hypertension, ventricular tachycardia, or in patients who are hypersensitive to it or to any of the components.

Active ingredient matches for Sinarest LEVO:

Phenylephrine in India.

Levocetirizine in India.


Unit description / dosage (Manufacturer)Price, USD
10's$ 0.64
Sinarest Levo 10+2.5 Tablet$ 0.06
Sinarest Levo Levocetirizine 2.5 mg, Phenylephrine 10 mg. TAB / 10$ 0.64
SINAREST LEVO TABLET 1 strip / 10 tablets each (Centaur Pharmaceuticals Pvt Ltd)$ 0.86
SINAREST LEVO tab 10's (Centaur (Samruddhi))$ 0.64
Sinarest Levo Levocetirizine 2.5 mg, Phenylephrine 10 mg. TAB / 10$ 0.64
Sinarest Levo Tablet (Centaur Pharmaceuticals Pvt Ltd)$ 0.10

List of Sinarest LEVO substitutes (brand and generic names):

SINAREST-PD SYR syr 60ml (Centaur)$ 0.49
Sinucold Cetirizine 5 mg, paracetamol325 mg, phenylephrine 5 mg. TAB / 10 (Intecare)$ 0.67
Sinucold Cetirizine 2.5 mg, paracetamol12.5 mg, phenylephrine 5 mg. O-SUSP / 60ml (Intecare)$ 0.56
SINUCOLD tab 10's (Intecare)$ 0.67
SINUCOLD oral susp 60ml (Intecare)$ 0.56
Sinurhon Tablet (Leben Laboratories Pvt. Ltd.)$ 0.53
Sislev 5mg TAB / 10x20 (Anabiosis)$ 7.94
SISLEV tab 5 mg x 10's (Anabiosis)$ 0.40
SIZLER tab 5 mg x 10's (Nitro Organics)$ 0.48
Skycett 5 mg Tablet (Adbio Organics Pvt Ltd)$ 0.05
Skycett Cold Tablet (Adbio Organics Pvt Ltd)$ 0.07
Skycett M Kid 2.5+5 Tablet (Adbio Organics Pvt Ltd)$ 0.08
Skycett M Plus 5+10 Tablet (Adbio Organics Pvt Ltd)$ 0.16
Spacet 5 mg Tablet (Spa Biological Labs)$ 0.10
SPALC 5 MG TABLET 1 strip / 10 tablets each (Seagull Labs (I) Pvt Ltd)$ 0.08
Spalc 5mg Tablet (Seagull Pharmaceutical Pvt Ltd)$ 0.01
Spazin L 5 mg Tablet (Sarthi Lifesciences)$ 0.04
SPENCET-L TABLET 1 strip / 10 tablets each (Spenchem Pharmaceuticals Pvt Ltd)$ 0.48
Spray; Nasal; Phenylephrine (Spirig)
Stalzine 5mg Tablet (Stallion Laboratories Pvt Ltd)$ 0.05
Starcet 5mg TAB / 10 (Pinnacle (Lupin Laboratories Ltd.))$ 0.47
5 mg x 10's (Pinnacle (Lupin Laboratories Ltd.))$ 0.47
Starcet 5 mg Tablet (Pinnacle (Lupin Laboratories Ltd.))$ 0.07
STARCET 5 MG TABLET 1 strip / 10 tablets each (Pinnacle (Lupin Laboratories Ltd.))$ 0.66
STARCET tab 5 mg x 10's (Pinnacle (Lupin Laboratories Ltd.))$ 0.47
Starcet Cold FC 500+60+2.5 Tablet (Lupin Laboratories Ltd.)$ 0.07
Starcet- A Levocetirizine diHCL 5mg, Ambroxol HCI 75mg CAP / 10$ 0.78
Sts Lwin DT 5 mg Tablet (ST Sharda Lifesciences)$ 0.02
Sudafed PE Congestion tablet 10 mg/1 (Johnson & Johnson Consumer Inc., Mc Neil Consumer Healthcare Division (US))

References

  1. PubChem. "phenylephrine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  2. PubChem. "Levocetirizine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "Levocetirizine". http://www.drugbank.ca/drugs/DB06282 (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Sinarest LEVO are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Sinarest LEVO. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

Consumer reported useful

No survey data has been collected yet


1 consumer reported price estimates

Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?
The below mentioned numbers have been reported by ndrugs.com website users about whether the Sinarest LEVO drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
Users%
Expensive1
100.0%


Consumer reported time for results

No survey data has been collected yet


4 consumers reported age

Users%
16-292
50.0%
6-152
50.0%


Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 29 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2024 ndrugs.com All Rights Reserved